$SPCX

SpaceX stock falls as Starship's test flight slips to Sept. 28, retail investors sell shares

SpaceX (SPCX) shares fell 2% on Friday after delaying Starship's orbital test flight to Sept. 28. The mission aims to deploy Starlink satellites. Retail investors sold $250M in shares, while Baron Capital's Ron Baron remains bullish, estimating Starlink's revenue at $18B today and potentially $1T in 10 years. Musk hinted at a possible merger with Tesla (TSLA).

Original reporting
Published Sep 18, 2026, 2:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 2:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX stock falls as Starship's test flight slips to Sept. 28, retail investors sell shares — source image
Decision brief

The 30-second read

$SPCXBearishMed
01

Why it matters

A six-day postponement to Sept. 28, plus a note that no Mechazilla catch is planned, shifts near-term expectations and coincides with reported retail selling.

02

Market read

Traders get a concrete schedule change for the first orbital Starship flight and a same-day sentiment read-through from retail selling.

03

What to watch

The article cites bullish commentary from a major backer and does not quantify probability-of-success or any technical issues behind the slip, so the market may be overreacting to schedule risk alone.

Relevance 7/10Novelty 6/10Timing: Friday session, ahead of the Sept. 28 orbital Starship test window.

Background

The piece frames SpaceX as a newly public name whose Starship first orbital flight is a key catalyst for Starlink economics and broader lunar and Mars ambitions.

Company-level read

Ticker impact

$SPCXBearishMedium confidence
Context

SpaceX shares fell over 2% after the Starship first orbital test flight was pushed to Sept. 28 from Sept. 22.

Expected impact

Choppy-to-lower near term, with volatility likely increasing into the Sept. 28 launch window.

Evidence & confidence

The article links the same-day pullback directly to the six-day slip of the first orbital flight and notes retail selling, which can amplify downside until the next confirmed milestone.

Market effects

Could spill over to sentiment for commercial space and satellite launch-adjacent themes, but the article is primarily single-name.

Limited, mostly US retail/sentiment-driven impact.

Low, as the catalyst is company-specific and not a broad macro or regulatory event.

Counterpoint

The delay may reduce execution risk, and the mission still targets orbital insertion, multiple orbits, and Starlink V3 deployment, which can keep longer-term bulls intact.

Key entities

  • SpaceX

    Subject of the article; shares drop after Starship first orbital test flight is delayed to Sept. 28.

  • Starship

    Vehicle whose first orbital flight schedule is pushed back, affecting the timeline for Starlink V3 satellite deployment.

  • Ron Baron

    Large backer quoted as remaining bullish on SpaceX’s satellite revenue and valuation potential.

  • JPMorgan

    Quoted via Barron’s for retail selling estimates over the past three weeks.

Related articles

$SPCXMedAI 8/10

NASA Hitches Ride with SpaceX for StarBurst Satellite. Is RocketLab the Big Loser?

NASA selected SpaceX (SPCX) for a Falcon 9 rideshare mission, including the StarBurst satellite, scheduled for no earlier than 2028. SpaceX reported $3.5B quarterly EBITDA and $93.5B cash, while Rocket Lab (RKLB) remains EBITDA-negative. The deal may impact small-launch providers like Rocket Lab, which has a 137% backlog jump and plans to debut its Neutron rocket in Q4 2026.

$RKLBMedAI 8/10

SpaceX vs. Rocket Lab – Which Space Stock Has More Upside, According to Analysts?

SpaceX (SPCX) and Rocket Lab (RKLB) are key players in the space industry. RKLB completed a $1.944B share offering for its Iridium (IRDM) acquisition, aiming to diversify into satellite communications. Analysts see 61.4% upside for RKLB. SPCX targets Starship's first orbital test flight and has a $300 price target, with 49.9% upside. Both companies are expanding into new markets, with analysts highlighting growth opportunities and risks.

$SPCXMedAI 8/10

SpaceX at $155: Should You Buy Into Momentum?

SpaceX (SPCX) trades at $155, up 8% in a month, with a $1.89T market cap. Q2 revenue grew 92% to $7.81B, and adjusted EBITDA rose 191% to $3.54B. Analysts' consensus target is $222.42, with bulls citing growth and bears highlighting valuation and execution risks. The stock is above its 50-day and 200-day moving averages but below its 52-week high.

$SPCXHighAI 8/10

SpaceX Nasdaq-100 rebalance: what the $15.5B to $22B passive buying event means for SPCX

SpaceX (SPCX) is set to see its Nasdaq-100 weighting more than double at Friday's close, triggering $15.5B to $22B in passive buying. The company's float has expanded due to recent lockup expirations, increasing its index weight. SPCX reported strong Q2 2026 revenue growth and is expected to turn profitable this year. Analysts warn that past index inclusions have seen post-rebalance declines due to institutional selling.